Angiographic validation of bedside markers of reperfusion

Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California 90048.

OBJECTIVES. We sought to validate with coronary angiography several primary and ancillary markers of reperfusion. BACKGROUND. The availability of bedside markers of reperfusion is of major importance in the thrombolytic therapy of acute myocardial infarction. However, the reliability of current markers is still controversial. METHODS. Changes in chest pain, ST segment elevation and heart rate and rhythm were assessed every 5 to 10 min for up to 3 h after initiation of recombinant tissue-type plasminogen activator therapy in 82 patients with acute myocardial infarction. Coronary angiography was performed within 24 h. RESULTS. At angiography, 69 of the 82 patients had a patent infarct-related artery with Thrombolysis in Myocardial Infarction trial (TIMI) grade 3 flow and a rapid and progressive decrease in chest pain and ST elevation. The pain resolved in 24 +/- 23 min (range 3 to 50). The ST elevation decreased by > or = 50% within 16 +/- 14 min (range 5 to 41). Accelerated idioventricular rhythm developed in 49% of patients and sinus bradycardia in 23%; conduction abnormalities and atrial fibrillation resolved. All markers appeared in close temporal proximity to the onset of an abrupt increase in plasma creatine kinase (CK) and CK-MB isoenzyme activity, a previously validated marker of the time of reperfusion. Before its final resolution, ST elevation transiently decreased and increased in 58% of patients. Comparison of one pretreatment and one posttreatment electrocardiogram significantly reduced the reliability of ST segment change as a marker of reperfusion. In 13 of 82 patients, the infarct-related artery demonstrated TIMI grade < or = 2 flow; in 9, pain and ST elevation did not lessen and CK and CK-MB activity showed no abrupt increase. The remaining four patients initially demonstrated a decrease in pain and ST elevation; however, within 3 h and before angiography, the recurrence of pain and ST elevation suggested reocclusion. CONCLUSIONS. A rapid and progressive decrease in pain and ST elevation is a reliable marker of reperfusion with TIMI grade 3 flow. Because ST elevation and pain often fluctuate before undergoing final resolution with reperfusion, frequent or continuous monitoring of ST elevation is essential for reliable recognition of the fact and time of reperfusion. Accelerated idioventricular rhythm and episodes of sudden sinus bradycardia, although specific to reperfusion, do not occur in all patients with reperfusion.

This article has been cited by other articles:

				M. Majidi, A. S. Kosinski, S. M. Al-Khatib, M. E. Lemmert, L. Smolders, A. van Weert, J. H.C. Reiber, D. Tzivoni, F. W.H.M. Bar, H. J.J. Wellens, et al. Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias Europace, August 1, 2008; 10(8): 988 - 997. [Abstract] [Full Text] [PDF]

				G De Luca, H Suryapranata, J P Ottervanger, J C A Hoorntje, A T M Gosselink, J-H Dambrink, M-J de Boer, and A W J v. Hof Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty Heart, January 1, 2008; 94(1): 44 - 47. [Abstract] [Full Text] [PDF]

				M. W. Krucoff, P. Johanson, R. Baeza, S. W. Crater, and M. Dellborg Clinical Utility of Serial and Continuous ST-Segment Recovery Assessment in Patients With Acute ST-Elevation Myocardial Infarction: Assessing the Dynamics of Epicardial and Myocardial Reperfusion Circulation, December 21, 2004; 110(25): e533 - e539. [Full Text] [PDF]

				G. De Luca, A. W.J van't Hof, M.-J. de Boer, J. P. Ottervanger, J. C.A Hoorntje, A.T.M. Gosselink, J.-H. E Dambrink, F. Zijlstra, and H. Suryapranata Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty Eur. Heart J., June 2, 2004; 25(12): 1009 - 1013. [Abstract] [Full Text] [PDF]

				J. A. de Lemos and E. Braunwald ST segment resolution as a tool for assessing the efficacy of reperfusion therapy J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1283 - 1294. [Abstract] [Full Text] [PDF]

				M. T. Roe, E. M. Ohman, A. C. P. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion J. Am. Coll. Cardiol., January 1, 2001; 37(1): 9 - 18. [Abstract] [Full Text] [PDF]

				A G C Sutton, P G Campbell, D J A Price, E D Grech, J A Hall, A Davies, M J Stewart, and M A de Belder Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method Heart, August 1, 2000; 84(2): 149 - 156. [Abstract] [Full Text] [PDF]

				A J O. Ophuis, F W Bar, F Vermeer, W Janssen, P A Doevendans, R J Haest, W R Dassen, and H J J Wellens Angiographic assessment of prospectively determined non-invasive reperfusion indices in acute myocardial infarction Heart, August 1, 2000; 84(2): 164 - 170. [Abstract] [Full Text] [PDF]

				A. Shah, G. S. Wagner, C. B. Granger, C. M. O'Connor, C. L. Green, K. M. Trollinger, R. M. Califf, and M. W. Krucoff Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis: Reexamining the "gold standard" for myocardial reperfusion assessment J. Am. Coll. Cardiol., March 1, 2000; 35(3): 666 - 672. [Abstract] [Full Text] [PDF]

				S. Matetzky, M. Novikov, L. Gruberg, D. Freimark, M. Feinberg, D. Elian, I. Novikov, E. Di Segni, O. Agranat, Y. Har-Zahav, et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1932 - 1938. [Abstract] [Full Text] [PDF]

				I.F. Purcell, N. Newall, and M. Farrer Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis QJM, June 1, 1999; 92(6): 327 - 333. [Abstract] [Full Text] [PDF]

				S. Matetzky, D. Freimark, P. Chouraqui, I. Novikov, O. Agranat, B. Rabinowitz, E. Kaplinsky, and H. Hod The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1326 - 1330. [Abstract] [Full Text] [PDF]

				I F Purcell, N Newall, and M Farrer Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes Heart, November 1, 1997; 78(5): 465 - 471. [Abstract] [Full Text] [PDF]

				C. Cobbaert, W. Th. Hermens, P. P. Kint, P. J. Klootwijk, F. Van de Werf, and M. L. Simoons Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteins Cardiovasc Res, January 1, 1997; 33(1): 147 - 155. [Abstract] [Full Text] [PDF]

				M. A. Arstall, J. Yang, I. Stafford, W. H. Betts, and J. D. Horowitz N-Acetylcysteine in Combination With Nitroglycerin and Streptokinase for the Treatment of Evolving Acute Myocardial Infarction : Safety and Biochemical Effects Circulation, November 15, 1995; 92(10): 2855 - 2862. [Abstract] [Full Text]

				E. T. Hasche, C. Fernandes, S. B. Freedman, and R. W. Jeremy Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans Circulation, August 15, 1995; 92(4): 710 - 719. [Abstract] [Full Text]

				F. Ottani, M. Galvani, D. Ferrini, F. Sorbello, P. Limonetti, D. Pantoli, and F. Rusticali Prodromal Angina Limits Infarct Size : A Role for Ischemic Preconditioning Circulation, January 15, 1995; 91(2): 291 - 297. [Abstract] [Full Text]